跳至主要内容
临床试验/ISRCTN47530284
ISRCTN47530284已完成Unknown

Effectiveness of remimazolam on preventing adverse reactions caused by carboprost tromethamine during cesarean section

Baotou Science and Technology Bureau (????????)0 个研究点目标入组 100 人开始时间: 2023年11月16日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Aged 24-45 years old
  • 2. Indication for cesarean section, planned elective cesarean section
  • 3. American Society of Anesthesiologists (ASA) grade I-II
  • 4. Presence of risk factors for uterine atony, such as scar pregnancy, multiple pregnancies, macrosomia, psychological stress, and making natural labor inappropriate.

排除标准

  • 1. Genital tract anomalies
  • 2. Coagulation disorders
  • 3. Allergy to drugs and related solvents intended for use during surgery
  • 4. Pre-existing conditions such as severe gastric ulcers, duodenal ulcers, reflux esophagitis, or other conditions that could lead to symptoms such as nausea, vomiting, chest discomfort, palpitations, abdominal pain, or diarrhea

研究者

发起方
Baotou Science and Technology Bureau (????????)

相似试验